BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $794,831,498 | -19.4% | 20,901,794 | -2.8% | 0.04% | -15.4% |
| Q2 2023 | $986,096,037 | +13.4% | 21,509,396 | +1.1% | 0.05% | +6.1% |
| Q1 2023 | $869,410,196 | -60.5% | 21,284,408 | -50.5% | 0.05% | -24.6% |
| Q4 2022 | $2,203,654,002 | +89.2% | 42,993,506 | +99.9% | 0.06% | -12.2% |
| Q3 2022 | $1,164,560,000 | -15.7% | 21,507,881 | +0.5% | 0.07% | -10.8% |
| Q2 2022 | $1,380,932,000 | -18.1% | 21,404,883 | -1.3% | 0.08% | 0.0% |
| Q1 2022 | $1,687,134,000 | -9.3% | 21,681,976 | +0.3% | 0.08% | -5.7% |
| Q4 2021 | $1,860,930,000 | +10.1% | 21,610,674 | +3.2% | 0.09% | -1.1% |
| Q3 2021 | $1,690,457,000 | +0.6% | 20,944,962 | +0.7% | 0.09% | 0.0% |
| Q2 2021 | $1,679,571,000 | -3.2% | 20,793,432 | +1.3% | 0.09% | -11.0% |
| Q1 2021 | $1,735,851,000 | +2.5% | 20,521,987 | -2.5% | 0.10% | -3.8% |
| Q4 2020 | $1,694,320,000 | -5.5% | 21,051,589 | -5.2% | 0.10% | -14.8% |
| Q3 2020 | $1,792,152,000 | -13.7% | 22,217,616 | -7.6% | 0.12% | -19.2% |
| Q2 2020 | $2,075,464,000 | +8.2% | 24,037,245 | +2.0% | 0.15% | -10.1% |
| Q1 2020 | $1,918,906,000 | -4.1% | 23,572,658 | -1.3% | 0.17% | +22.6% |
| Q4 2019 | $2,001,399,000 | -5.6% | 23,872,320 | -1.3% | 0.14% | -13.3% |
| Q3 2019 | $2,120,911,000 | +9.6% | 24,189,517 | +2.6% | 0.16% | +9.7% |
| Q2 2019 | $1,935,386,000 | -0.9% | 23,568,938 | -1.7% | 0.14% | -5.3% |
| Q1 2019 | $1,953,762,000 | +27.3% | 23,974,802 | +3.1% | 0.15% | +8.6% |
| Q4 2018 | $1,534,798,000 | -15.9% | 23,251,518 | -1.8% | 0.14% | 0.0% |
| Q3 2018 | $1,824,466,000 | +8.4% | 23,666,594 | +3.8% | 0.14% | -0.7% |
| Q2 2018 | $1,682,862,000 | +10.3% | 22,790,524 | -2.9% | 0.14% | +8.5% |
| Q1 2018 | $1,526,003,000 | -4.7% | 23,462,533 | -5.3% | 0.13% | +0.8% |
| Q4 2017 | $1,600,709,000 | +2.4% | 24,763,438 | -0.6% | 0.13% | -4.4% |
| Q3 2017 | $1,563,412,000 | +2.3% | 24,914,737 | -1.3% | 0.14% | 0.0% |
| Q2 2017 | $1,528,269,000 | +14.8% | 25,243,761 | -1.6% | 0.14% | +13.4% |
| Q1 2017 | $1,330,814,000 | +20.0% | 25,660,985 | +2.6% | 0.12% | +14.4% |
| Q4 2016 | $1,109,052,000 | -3.7% | 25,012,404 | +3.4% | 0.10% | -10.3% |
| Q3 2016 | $1,151,726,000 | +1.8% | 24,195,966 | -3.3% | 0.12% | -4.9% |
| Q2 2016 | $1,131,836,000 | +9.9% | 25,029,539 | -0.1% | 0.12% | +9.9% |
| Q1 2016 | $1,029,658,000 | +7.5% | 25,064,562 | -0.2% | 0.11% | +5.7% |
| Q4 2015 | $958,030,000 | -44.9% | 25,111,995 | -1.1% | 0.10% | -41.3% |
| Q1 2015 | $1,740,024,000 | -6.8% | 25,401,847 | -0.3% | 0.18% | -3.8% |
| Q4 2014 | $1,867,829,000 | +4.3% | 25,485,486 | +2.1% | 0.19% | -3.6% |
| Q3 2014 | $1,790,623,000 | +1.1% | 24,949,468 | +1.9% | 0.19% | +1.0% |
| Q2 2014 | $1,770,670,000 | -0.1% | 24,490,581 | +1.6% | 0.19% | -5.4% |
| Q1 2014 | $1,773,196,000 | -48.3% | 24,098,966 | -52.1% | 0.20% | -7.3% |
| Q4 2013 | $3,429,383,000 | +109.5% | 50,352,431 | +102.0% | 0.22% | +7.9% |
| Q3 2013 | $1,637,055,000 | -5.8% | 24,920,882 | -0.6% | 0.20% | -10.6% |
| Q2 2013 | $1,737,260,000 | – | 25,079,415 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |